Zobrazeno 1 - 10
of 139
pro vyhledávání: '"Biller BM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Colao A (AUTHOR), Petersenn S (AUTHOR), Newell-Price J (AUTHOR), Findling JW (AUTHOR), Gu F (AUTHOR), Maldonado M (AUTHOR), Schoenherr U (AUTHOR), Dipl-Biol (AUTHOR), Mills D (AUTHOR), Salgado LR (AUTHOR), Biller BM (AUTHOR), Pasireotide B2305 Study Group (CORPORATE AUTHOR)
Publikováno v:
New England Journal of Medicine. 3/8/2012, Vol. 366 Issue 10, p914-924. 11p.
Autor:
Marco Losa, Francesco Cavagnini, Elena Valassi, Francesca Pecori Giraldi, Anne Klibanski, Beverly M. K. Biller, Brooke Swearingen, Pietro Mortini, Douglas Hayden
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 95:601-610
Background: Transsphenoidal surgery (TSS) is the treatment of choice for Cushing’s disease (CD). Postoperative hypercortisolemia mandates further therapy. Objective: The aim of the study was to characterize patients without immediate postoperative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0fa3f48bbcf4f0ce993cb0c1fbf495f
https://doi.org/10.1210/jc.2009-1672
https://doi.org/10.1210/jc.2009-1672
Autor:
Mario Maldonado, Rosario Pivonello, Maria Fleseriu, Catherine Watson, Ann Taylor, Marco Boscaro, Beverly M. K. Biller, Yiming Zhang, Xavier Bertagna, Amir H. Hamrahian, Paul Robinson
The clinical features and increased mortality associated with Cushing's syndrome result from a chronic excess of circulating cortisol. As LCI699 potently inhibits 11β-hydroxylase, which catalyzes the final step of cortisol synthesis, it is a potenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07bd7b31514a3a5d30dd80dc1b116bbb
http://hdl.handle.net/11588/569185
http://hdl.handle.net/11588/569185
Autor:
Annamaria Colao, Stephan Petersenn, John Newell-Price, James W. Findling, Feng Gu, Mario Maldonado, Ulrike Schoenherr, null Dipl.-Biol., David Mills, Luiz Roberto Salgado, Beverly M.K. Biller
Publikováno v:
The New England Journal of Medicine
The New England Journal of Medicine, 2012, 366 (10), pp.914-924. ⟨10.1056/NEJMoa1105743⟩
Colao, A, Petersenn, S, Newell-Price, J, Findling, J W, Gu, F, Maldonado, M, Schoenherr, U, Mills, D, Salgado, L R, Biller, B M K, Pasireotide B2305 Study Group & Jørgensen, J O L 2012, ' A 12-month phase 3 study of pasireotide in Cushing's disease ', Briefings from the New England Journal of Medicine, vol. 366, no. 10, pp. 914-24 . https://doi.org/10.1056/NEJMoa1105743
The New England Journal of Medicine, 2012, 366 (10), pp.914-924. ⟨10.1056/NEJMoa1105743⟩
Colao, A, Petersenn, S, Newell-Price, J, Findling, J W, Gu, F, Maldonado, M, Schoenherr, U, Mills, D, Salgado, L R, Biller, B M K, Pasireotide B2305 Study Group & Jørgensen, J O L 2012, ' A 12-month phase 3 study of pasireotide in Cushing's disease ', Briefings from the New England Journal of Medicine, vol. 366, no. 10, pp. 914-24 . https://doi.org/10.1056/NEJMoa1105743
International audience; BACKGROUND: Cushing's disease is associated with high morbidity and mortality. Pasireotide, a potential therapy, has a unique, broad somatostatin-receptor-binding profile, with high binding affinity for somatostatin-receptor s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e704eedf831e19fc42b4f644829e7b8
https://pubmed.ncbi.nlm.nih.gov/22646647
https://pubmed.ncbi.nlm.nih.gov/22646647
Autor:
Shimatsu A; Omi Medical Center, Kusatsu 525-8585, Japan., Biller BM; Neuroendocrine and Pituitary Tumor Clinical Center, Massachusetts General Hospital, Boston, MA 02114, USA., Fleseriu M; Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health & Science University, Portland, OR 97239, USA., Pivonello R; Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples 80131, Italy., Lee EJ; Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, South Korea., Leelawattana R; Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand., Kim JH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, South Korea., Walia R; Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India., Yu Y; Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China., Liao Z; Division of Endocrinology, Sun Yat-sen University, Guangzhou 510275, China., Piacentini A; Recordati SpA, Milan 20148, Italy., Pedroncelli AM; Recordati AG, Basel 4057, Switzerland.; Current Affiliation: Camurus AB, Lund 223 62, Sweden., Snyder PJ; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Publikováno v:
Endocrine journal [Endocr J] 2024 Dec 02; Vol. 71 (12), pp. 1103-1123. Date of Electronic Publication: 2024 Aug 23.
Autor:
Fleseriu M; Oregon Health and Science University, Portland, OR, USA., Auchus RJ; University of Michigan Medical School, Ann Arbor, MI, USA., Greenman Y; Tel Aviv University, Tel Aviv, Israel., Zacharieva S; Medical University-Sofia, Sofia, Bulgaria., Geer EB; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Salvatori R; Johns Hopkins University, Baltimore, MD, USA., Pivonello R; Università Federico II di Napoli, Naples, Italy., Feldt-Rasmussen U; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kennedy L; Cleveland Clinic, Cleveland, OH, USA., Buchfelder M; University Hospital Erlangen, Erlangen, Germany., Biller BM; Massachusetts General Hospital, Boston, MA, USA., Cohen F; Xeris Biopharma Holdings, Inc., Chicago, IL, USA., Heaney AP; University of California Los Angeles School of Medicine, Los Angeles, CA, USA.
Publikováno v:
European journal of endocrinology [Eur J Endocrinol] 2022 Nov 24; Vol. 187 (6), pp. 859-871. Date of Electronic Publication: 2022 Nov 24 (Print Publication: 2022).
Autor:
Burman P; Department of Endocrinology, Skånes University Hospital, University of Lund, 20502 Malmö, Sweden., van Beek AP; Department of Endocrinology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Biller BM; Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114., Camacho-Hübner C; Pfizer Endocrine Care, Pfizer Inc., New York, New York 10017; and., Mattsson AF; Pfizer Endocrine Care, Pfizer Health AB, 19091 Sollentuna, Sweden.
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2017 Mar 01; Vol. 102 (3), pp. 1051-1058.
Autor:
Weber MM; Department of Endocrinology and Metabolism, Medical Clinic, University of Mainz, Mainz, Germany., Biller BM; Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA., Pedersen BT; Epidemiology, Novo Nordisk A/S, Søborg, Denmark., Pournara E; Novo Nordisk Health Care AG, Zurich, Switzerland., Christiansen JS; Department of Endocrinology and Diabetes, MEA, Aarhus University Hospital, NBG, Aarhus, Denmark., Höybye C; Department of Endocrinology, Metabolism and Diabetology, Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
Clinical endocrinology [Clin Endocrinol (Oxf)] 2017 Feb; Vol. 86 (2), pp. 192-198. Date of Electronic Publication: 2016 Nov 21.
Autor:
Tritos NA; Neuroendocrine UnitMassachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA ntritos@mgh.harvard.edu., Chanson P; Assistance Publique-Hôpitaux de ParisHôpitaux Universitaires Paris-Sud, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin Bicêtre, France.; Institut National de la Santé et de la Recherche Médicale U1185Fac Med Paris Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France., Jimenez C; Endocrine Neoplasia and Hormonal DisordersThe University of Texas MD Anderson Cancer Center, Houston, Texas, USA., King D; Endocrine CarePfizer, Inc, Lawrenceville, New Jersey, USA., Jönsson PJ; Pfizer Health ABSollentuna, Sweden., Klibanski A; Neuroendocrine UnitMassachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Biller BM; Neuroendocrine UnitMassachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
European journal of endocrinology [Eur J Endocrinol] 2017 Feb; Vol. 176 (2), pp. 213-220. Date of Electronic Publication: 2016 Nov 15.